We are live on ! Find out more
IART icon

Integra LifeSciences
IART

223 hedge funds and large institutions have $2.96B invested in Integra LifeSciences in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 61 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

477% more call options, than puts

Call options by funds: $12M | Put options by funds: $2.08M

185.69% more ownership

Funds ownership: 0% → 185.69% (+186%)

56% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 61

8% more capital invested

Capital invested by funds: $2.75B → $2.96B (+$211M)

5% less funds holding

Funds holding: 234 → 223 (-11)

22% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 41

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
223
Holders Change
-11
Holders Change %
-4.7%
% of All Funds
5.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
32
Increased
95
Reduced
61
Closed
41
Calls
$12M
Puts
$2.08M
Net Calls
+$9.9M
Net Calls Change
+$1.89M

Top Buyers

1
Invesco
Invesco
Georgia
+$50.1M
2
JHIU
Janus Henderson Investors US
Colorado
+$41.6M
3
EAM
Eagle Asset Management
Florida
+$35.7M
4
CIP
Champlain Investment Partners
Vermont
+$27.9M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$21.4M

Top Sellers

1
WHG
Westwood Holdings Group
Texas
-$36.6M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$35.3M
3
CCI
Columbus Circle Investors
-$25.7M
4
SAM
Silvercrest Asset Management
New York
-$20.3M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$14.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
226
Silvercrest Asset Management
New York
– -$20.3M -491,318 Closed
Adage Capital Partners
227
Adage Capital Partners
Massachusetts
– -$14.4M -350,000 Closed
Arrowstreet Capital
228
Arrowstreet Capital
Massachusetts
– -$14.4M -348,646 Closed
SGH
229
Sivik Global Healthcare
Connecticut
– -$3.71M -90,000 Closed
EI
230
EAM Investors
California
– -$2.97M -72,064 Closed
ICRM
231
Insight Capital Research & Management
California
– -$2.53M -61,236 Closed
Macquarie Group
232
Macquarie Group
Australia
– -$2.43M -58,800 Closed
SCM
233
Sandler Capital Management
New York
– -$2.15M -51,962 Closed
SCM
234
Stevens Capital Management
Pennsylvania
– -$2.12M -51,372 Closed
ACM
235
Americafirst Capital Management
California
– -$1.64M -39,690 Closed
Renaissance Technologies
236
Renaissance Technologies
New York
– -$1.57M -38,060 Closed
CSS
237
Cubist Systematic Strategies
Connecticut
– -$1.42M -34,462 Closed
N
238
Nuveen
North Carolina
– -$1.17M -28,232 Closed
Walleye Trading
239
Walleye Trading
New York
– -$1.15M -27,834 Closed
Jane Street
240
Jane Street
New York
– -$1.14M -27,608 Closed
FMT
241
First Mercantile Trust
Tennessee
– -$1.06M -25,590 Closed
EMG
242
Ellington Management Group
Connecticut
– -$792K -19,200 Closed
Acadian Asset Management
243
Acadian Asset Management
Massachusetts
– -$746K -18,094 Closed
Tudor Investment Corp
244
Tudor Investment Corp
Connecticut
– -$661K -16,010 Closed
DTL
245
Dynamic Technology Lab
Singapore
– -$644K -15,590 Closed
MF
246
Magnetar Financial
Illinois
– -$535K -12,952 Closed
UFF
247
USA Financial Formulas
Michigan
– -$522K -12,646 Closed
TD Asset Management
248
TD Asset Management
Ontario, Canada
– -$338K -8,200 Closed
HCM
249
Highbridge Capital Management
New York
– -$336K -8,140 Closed
AIM
250
Assured Investment Management
New York
– -$326K -7,900 Closed
7 8 9
10
11

IART Hedge Fund Activity: Q4 2016 in Review

223 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2016, worth a combined $2.96B — up 7.7% from $2.75B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of IART and 32 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 95 added.

The largest buyer was Invesco, adding an estimated $50.1M. The largest seller was Westwood Holdings Group, cutting an estimated $36.6M.

  • 223 institutional investors held Integra LifeSciences (IART) as of Q4 2016, down from 234 in Q3 2016.
  • Funds reported $2.96B of Integra LifeSciences stock for Q4 2016, up 7.7% quarter-over-quarter.
  • 32 funds opened new Integra LifeSciences positions in Q4 2016 and 41 closed out, a net change of -9 holders.
  • The largest Integra LifeSciences buyer in Q4 2016 was Invesco, an estimated $50.1M added.
  • The largest Integra LifeSciences seller in Q4 2016 was Westwood Holdings Group, an estimated $36.6M sold.

Based on aggregated 13F filings for Q4 2016.